Lippo General Insurance Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Lippo General Insurance Tbk. trades at Rp670 (market cap 2.03T, 3.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Lippo General Insurance Tbk. is far larger — about 12.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 3.5K). Which is the better fit depends on your goals.
| LPGI | OBAT | |
|---|---|---|
Market Cap | 2.03T | 167.37B |
Volume | 3.5K | 96.7K |
Lot | 35 | 967 |
Turnover | 2.31M | 23.82M |
Average Price | 659.14 | 246.34 |
Value | 2.31M | 23.82M |
Indicative Equilibrium Price | 675 | 248 |
Indicative Equilibrium Volume | 100 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lippo General Insurance Tbk (the Company) was established and domiciled in Surabaya based on Notarial Deed No. 1 of Adasiah Harahap, S.H., notary in Jakarta, dated September 6, 1963, under the name of PT Asuransi Brawidjaja and was changed to PT Maskapai Asuransi Marga Pusaka based onNotarial Deed No. 46 of Misahardi Wilamarta, S.H., notary in Jakarta, subtitute notary of Adasiah Harahap, S.H., notary in Jakarta.
Read more on LPGI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →